Table 4.
Antibiotic treatment in patients with Klebsiella pneumoniae liver abscess and Streptococcus milleri liver abscess.
| KLA | Streptococcus milleri | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hong Kong (38) (n = 140) | Singapore (4) (n = 109) | Taiwan (62) (n = 110) | Turkey (61) (n = 85) | Hong Kong (38) (n = 21) | ||||||
| Duration (days) | Efficiency | Duration (days) | Efficiency | Duration (days) | Efficiency | Duration (days) | Efficiency | Duration (days) | Efficiency | |
| Extended-spectrum penicillin* | 21.7 | 48 (34.3%) | — | — | — | — | — | 4 (4.7%) | 15.4 | 11 (52.4%) |
| First- and second-generation cephalosporins§ | 21.7 | 30 (21.4%) | 32 ± 13 | 24 (22.0%) | — | 104 (94.5%) | — | — | 15.4 | 4 (19%) |
| Third- and fourth-generation cephalosporins▲ | 21.7 | 50 (35.7%) | 32 ± 13 | 71 (65.1%) | — | 4 (3.6%) | — | 5 (5.9%) | 15.4 | 3 (14.3%) |
| Carbapenems∧ | — | — | 32 ± 13 | 13 (11.9%) | — | — | — | 42 (49.4%) | — | — |
| Aminoglycosides# | — | — | — | 1 (0.9%) | — | 104 (94.5%) | — | 2 (2.4%) | — | — |
| Quinolone** | — | — | — | — | — | — | — | 11 (12.9%) | — | — |
*Piperacillin-tazobactam, ticarcillin-clavulanate; §cefazolin; ▲ceftriaxone, cefepime; ∧ertapenem, meropenem; #amikacin; **ciprofloxacin.